98%
921
2 minutes
20
Introduction: Preexisting anticoagulation is common among geriatric trauma patients. Geriatric trauma patients have a higher risk of mortality compared to younger patients. We sought to evaluate the association of preexisting anticoagulation with mortality in a group of geriatric trauma patients.
Methods: A retrospective review of geriatric trauma patients was conducted for those admitted to a Level 1 trauma center from January 2018 to December 2020. Vital signs, demographics, injury characteristics, laboratory data, and mortality were all collected. Multivariable logistic regression analysis was performed for the association of preexisting anticoagulation and a primary endpoint of all-cause mortality. These groups were controlled for preexisting comorbidities, injury severity scores, and systolic blood pressure in the emergency department.
Results: Four thousand four hundred thirty-two geriatric patients were admitted during the study period. This cohort was made up of 36.9% men and 63.1% women. Three thousand eight hundred fifty-nine (87.2%) were white; the average age was 81±8.5 years, and the median injury severity score (ISS) was 5. The mean systolic blood pressure was 150±32 mmHg, mean heart rate was 81±16 bpm, mean lactate was 2.3±1.3, mean hematocrit was 37.3±8.8, and mean international normalized ratio (INR) was 1.7±10.3. One thousand five hundred ninety-two (35.9%) patients were on anticoagulation (AC) upon presentation. One hundred and sixty-five (3.7%) mortalities were recorded. Multivariable logistic regression analysis results show that preexisting anticoagulation [ odds ratio (OR) 1.92, 95% CI 1.36-2.72] was independently predictive of death. The analysis was adjusted for systolic BP in the emergency department less than90 mmHg (OR 5.55, 95% CI 2.83-10.9), having more than 1 comorbidity (OR 2.30, 95% CI 1.57-3.38) and ISS (OR 1.13, 95% CI 1.10-1.15).
Conclusion: Our study indicates that preexisting anticoagulation is associated with mortality among geriatric trauma patients.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473288 | PMC |
http://dx.doi.org/10.1097/MS9.0000000000000927 | DOI Listing |
Cureus
July 2025
Internal Medicine, AdventHealth Orlando, Orlando, USA.
Evans syndrome is a rare condition that can be seen among patients with pre-existing rheumatological disorders such as lupus, rheumatoid arthritis, or adult-onset Still's disease. There is an association between positive anti-phospholipid antibodies and the development of Evans syndrome, but the underlying pathophysiology remains unknown. To our knowledge, this is one of the few case reports to date that describes the development of Evans syndrome triggered by parvovirus B19 in patients with pre-existing positive antiphospholipid antibodies.
View Article and Find Full Text PDFJ Stroke Cerebrovasc Dis
October 2025
Department of Neurology, Nippon Medical School, Tokyo, Japan.
Background: The incidence of patients with stroke and preexisting dementia (PED) increases with age. This study aimed to elucidate the unclear relationship between PED and functional outcomes of acute ischemic stroke (AIS) and atrial fibrillation (AF).
Methods: We analyzed data from 493 patients (median age, 80 years; 43.
FEBS Lett
August 2025
Department of Bioscience and Bioinformatics, School of Computer Science and Systems Engineering, Kyushu Institute of Technology, Fukuoka, Japan.
A Streptococcus sobrinus glucansucrase (i.e., glucosyltransferase-I) elongates α-1, 3-linked glucose chains at pre-existing branch points of dextran, and its activity is enhanced by primer dextran.
View Article and Find Full Text PDFSemin Thromb Hemost
August 2025
Department of Pharmacy and Pharmaceutical Sciences, Faculty of Science, National University of Singapore, Singapore.
The coronavirus disease 2019 (COVID-19) pandemic introduced unprecedented disruptions to health care delivery, compelling rapid adaptations in anticoagulation management. Direct oral anticoagulants (DOACs), already displacing warfarin due to their convenience and reduced monitoring requirements, appeared well-positioned for broader adoption during pandemic-induced lockdowns. This commentary examines whether the pandemic catalyzed a meaningful shift in anticoagulant prescribing patterns from vitamin K antagonists (VKAs) to DOACs, drawing on data from the United Kingdom, Australia, the United States, Europe, and Asia.
View Article and Find Full Text PDFSci Rep
July 2025
Disease Prevention and Control Center of Huaxi District, Guiyang City, Guizhou Province, China.
Coronavirus Disease-2019 (COVID-19) contributes to dysfunction and increased mortality in patients with acute ischemic stroke (AIS). However, whether COVID-19 causes early neurological deterioration (END) in patients with AIS and its underlying influencing factors are currently unclear.To ascertain the autonomous risk factors associated with END in stroke cases related to COVID-19.
View Article and Find Full Text PDF